AAHRPP Publishes Metrics on Performance of Human Research Protection Programs
The Association for the Accreditation of Human Research Protection Programs, Inc. announced the publication of a performance study on human research protection programs (HRPPs). The study is available in AAHRPP Advance and on the organization's Web site.
From data supplied by client organizations in 2009, AAHRPP has compiled an information database to help research organizations, researchers, sponsors, and government agencies identify and support high performance in HRPPs. One hundred ninety-six organizations, of which 8.7 percent were independent IRBs, 17.9 percent were hospitals, 27 percent were universities, 41.8 percent were VA medical centers, and 4.6 percent were other research organizations, submitted data. Following the demand for evidence-based practice in other areas, AAHRPP is leading an initiative to describe the current practices for human research protection for the research enterprise. The ultimate goal is to define and measure quality-in terms of both efficiency and the protections that organizations, IRBs, and researchers provide to research participants.
"The availability of objective data should drive bench-marking efforts to improve quality both within an organization and across the research enterprise," said Dr. Marjorie Speers, Ph.D., President and CEO. As part of the benchmarking process, individual organizations, both accredited and non-accredited, can compare their HRPPs to the aggregate of other accredited programs. Over time, they will be able to compare their current performance with their performance in the past.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
